Myomo (MYO) Selling, General & Administrative (2016 - 2025)
Myomo (MYO) Selling, General & Administrative (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn | 3.74 Bn |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn | 2.28 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn | 1.78 Bn |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn | 522.20 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 349.70 Mn |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn | 1.12 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn | -207.22 Mn |
| 10 | Myomo | 43.01 Mn | 24.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 3.41 Mn |
| Mar 31, 2025 | 3.94 Mn |
| Dec 31, 2024 | 3.60 Mn |
| Sep 30, 2024 | 3.25 Mn |
| Jun 30, 2024 | 2.66 Mn |
| Mar 31, 2024 | 2.87 Mn |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | 2.41 Mn |
| Jun 30, 2023 | 2.55 Mn |
| Mar 31, 2023 | 2.47 Mn |
| Dec 31, 2022 | 4.36 Mn |
| Sep 30, 2022 | 4.77 Mn |
| Jun 30, 2022 | 4.66 Mn |
| Mar 31, 2022 | 4.66 Mn |
| Dec 31, 2021 | 5.04 Mn |
| Sep 30, 2021 | 4.66 Mn |
| Jun 30, 2021 | 4.20 Mn |
| Mar 31, 2021 | 4.12 Mn |
| Dec 31, 2020 | 4.05 Mn |